Inclusion Criteria

Inclusion Criteria

- Has Candidemia or invasive candidiasis documented by typical clinical signs and
symptoms and confirmed by fungal culture or histologic confirmation

Exclusion Criteria

- Has abnormal liver test parameters, e.g., AST or ALT > 10 times upper limit of normal

- Has life expectancy judged to be less than 5 days

- De novo patients who have received a systemic antifungal agent for the treatment of
this episode of candidemia or invasive candidiasis for more than 48 hours prior to
the first dose of FK463; or efficacy failure patients who have received =< 5 days of
prior systemic antifungal therapy for the treatment of this episode of candidemia or
invasive candidiasis

- Require treatment with topical or systemic antifungal agents for conditions other
than candidemia or invasive candidiasis